Trial Profile
Phase III trial of cebranopadol for chronic back pain
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 22 Nov 2018
Price :
$35
*
At a glance
- Drugs Cebranopadol (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors Assertio Therapeutics
- 23 Nov 2015 New trial record